5 Best Marijuana Stocks To Buy Now

3. Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)

Number of Hedge Fund Holders: 43

Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) is a global biopharmaceutical business dedicated to improving patients’ lives via identifying, developing, and commercializing effective medications that meet unmet medical needs. Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)’s subsidiary, GW Pharmaceuticals, is a global leader in the research, production, and delivery of regulatory-approved cannabis-based medicine.

On November 09, 2022, Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) reported its Q3 2022 results, posting revenue of $940.6 million for the quarter, recording a growth of 12.2% over the same period last year. The company’s Normalized EPS of $5.17 beat the market estimates by $0.50.

43 hedge funds were long on the company’s stock at the end of the third quarter, according to Insider Monkey’s database. Polaris Capital Management had the biggest long position in the company at the end of Q3 2022.